Cdr Grafting
CDR Grafting is a recombinant antibody engineering technique in which the complementarity-determining regions (CDRs) of a non-human antibody are transplanted into a human antibody framework to retain antigen specificity while reducing immunogenicity.
30
Publications
1.7K
Citations
223
Authors
59
Institutions
Publications per year
2017–2026
8
Variants
Complementarity-determining Region Grafting
Parents
30
1–5 of 30
223
University of California, San Francisco, United States
2 publications · 109 citations
2
h-index
University of California, San Francisco, United States
2 publications · 109 citations
2
h-index
2
h-index
2
h-index
University of California, San Francisco, United States
2 publications · 109 citations
2
h-index
1–5 of 223
59

Leiden University Medical Center
Leiden, The Netherlands
2 h-index
4 publications
218 citations
Scripps Research Institute
San Diego, United States
2 h-index
9 publications
1.3K citations

China Pharmaceutical University
Nanjing, China
2 h-index
18 publications
581 citations
University of Zurich
Zurich, Switzerland
2 h-index
9 publications
544 citations
University of California, San Francisco
San Francisco, United States
2 h-index
28 publications
1.5K citations

San Francisco General Hospital
San Francisco, United States
2 h-index
2 publications
109 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
2 h-index
13 publications
627 citations
University of California, Irvine
Irvine, United States
1 h-index
4 publications
232 citations
1–8 of 59
PEDS · 7 publications · 522 citations
7
h-index
2 publications · 148 citations
2
h-index
2 publications · 80 citations
2
h-index
2 publications · 151 citations
2
h-index
1 publications · 58 citations
1
h-index
1–5